RSS-Feed abonnieren

DOI: 10.1055/s-0042-1742430
Dealing with a Pediatric Posterior Fossa Tumor after COVID-19 Infection: Report of One Case
Manejo de um tumor da fossa posterior em paciente pediátrica após infecção por COVID-19: Relato de um caso
Plain Language Summary
Having the issue of coronavirus disease 2019 (COVID-19) in mind, there is always a dilemma surrounding elective and non-urgent neurosurgical operations. The unanswered question is regarding whether there is any post-COVID-19 complications that hinder a patient from becoming a candidate for a neurosurgical operation. If that is the case, what should we do?
In the present article, we report our single-center experience with an unusual bleeding during the operation of a huge cerebellar tumor in a girl previously infected with COVID-19. In the end, we recommend our experience to our colleagues.
Abstract
There are still some conditions that pediatric neurosurgeons may face in the context of coronavirus disease 2019 (COVID-19) which have not been fully addressed so far. Authors have postulated an ongoing inflammatory myocardial status in a significant proportion of patients who have recovered from COVID-19. We report our experience with a 10-month-old girl who had recovered form COVID-19 and had a case of fourth-ventricle mass in the midline of the posterior fossa. She was scheduled for microneurosurgical resection of the mass following the insertion of a ventriculoperitoneal shunt. There were no significant issues regarding the induction of anesthesia. A midline suboccipital approach was chosen, and the patient was fully prepared and draped. Suboccipital soft tissues and muscles were dissected layer by layer through the midline avascular line. A marked gush of blood off the midline was observed during the opening in Y of the dura mater. Then, we started to approach the occipital sinus. However, there was an unusual loss of ∼ 200 mL of blood lost from this area. Despite the proper packed-cell transfusion, the patient developed bradycardia and a sudden rhythm of asystole. The cardiopulmonary cerebral resuscitation (CPCR) was initiated immediately. Despite the maximal effort, the heart rate did not change and remained asystole. We recommend that pediatric neurosurgeons postpone the procedures to be performed in patients who have recovered from COVID-19 for more than one month after a thorough preoperative cardiac evaluation has been performed.
Resumo
Ainda existem algumas condições que os neurocirurgiões pediátricos podem enfrentar no contexto da doença por coronavírus 2019 (COVID-19) que não foram totalmente abordadas até agora. Os autores postularam um estado inflamatório miocárdico contínuo em uma proporção significativa de pacientes que se recuperaram da COVID-19. Relatamos nossa experiência com uma menina de 10 meses que se recuperou da COVID-19 e teve um caso de massa no quarto ventrículo na linha média da fossa posterior. Ela foi programada para ressecção microneurocirúrgica da massa após a inserção de uma derivação ventrículo-peritoneal. Não houve problemas significativos em relação à indução da anestesia. Uma abordagem suboccipital na linha média foi escolhida e a paciente foi totalmente preparada e coberta. Tecidos moles e músculos suboccipitais foram dissecados camada por camada através da linha avascular da linha média. Durante a abertura em Y da dura-máter observou-se um jorro marcado de sangue na linha média. Em seguida, iniciamos a abordagem do seio occipital. No entanto, houve uma perda incomum de 200 ml de sangue perdido nesta área. Apesar da transfusão de hemácias adequada, a paciente evoluiu com bradicardia e ritmo súbito de assistolia. A ressuscitação cerebral cardiopulmonar (RCCP) foi iniciada.
Ethical Considerations
Approval from the institutional review boardd was obtained following the initial drafting of the present article.
Publikationsverlauf
Eingereicht: 14. August 2021
Angenommen: 13. Oktober 2021
Artikel online veröffentlicht:
04. April 2022
© 2022. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Valverde I, Singh Y, Sanchez-de-Toledo J. et al; AEPC COVID-19 Rapid Response Team*. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe. Circulation 2021; 143 (01) 21-32
- 2 Pande RK, Bhalla A, Myatra SN, Yaddanpuddi LN, Gupta S, Sahoo TK. et al. Procedures in COVID-19 Patients. Part II 2020; 24 (Suppl. 05) 272-279
- 3 Loggetto SR, Aparecida J, Braga P. Hematology, Transfusion and Cell Therapy Hemoglobinopathy and pediatrics in the time of. Hematol Transfus Cell Ther 2020
- 4 Shchedrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther 2021; 19 (01) 5-14 [Internet]
- 5 Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr 2021; 110 (03) 914-921
- 6 Ley-Vega L. Potential Heart Problems in Convalescent COVID-19 Children: Alert from a Cuban Study. MEDICC Rev 2021; 23 (02) 76